| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |